Biscayne NeuroTherapeutics
Biscayne Pharmaceuticals discovers and develops novel therapies based on growth hormone-releasing hormone (GHRH) analogs.
Employees
Enterprise value
$185m
loading funding rounds…
Quark Venture(exited)
Mesa Verde Venture Partners(exited)
GF Securities(exited)
The Reich Group(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.